A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: Survival and progression-free survival

MLA

T Ledent, et al. “A Retrospective Analysis of the Results of p(65) + Be Neutrontherapy for the Treatment of Prostate Adenocarcinoma at the Cyclotron of Louvain-La-Neuve. Part I: Survival and Progression-Free Survival.” Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique, vol. 5, no. 3, July 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c1a4dc5722b6dc2c038677dbc3e7ad6&authtype=sso&custid=ns315887.

APA

T Ledent, F Lhoas, V Remouchamps, Pierre Scalliet, Françoise Richard, André Wambersie, P. Van Cangh, M. van Glabbeke, & Desmond Curran. (2001). A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: Survival and progression-free survival. Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique, 5(3).

Chicago

T Ledent, F Lhoas, V Remouchamps, Pierre Scalliet, Françoise Richard, André Wambersie, P. Van Cangh, M. van Glabbeke, and Desmond Curran. 2001. “A Retrospective Analysis of the Results of p(65) + Be Neutrontherapy for the Treatment of Prostate Adenocarcinoma at the Cyclotron of Louvain-La-Neuve. Part I: Survival and Progression-Free Survival.” Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique 5 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c1a4dc5722b6dc2c038677dbc3e7ad6&authtype=sso&custid=ns315887.